Curanex Financial Statements From 2010 to 2026

CURX Stock   0.30  0.02  8.36%   
Curanex Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Curanex Pharmaceuticals' valuation are provided below:
Market Capitalization
7.8 M
Earnings Share
(0.02)
We have found thirty available fundamental signals for Curanex Pharmaceuticals Common, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Curanex Pharmaceuticals Common prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.
Check Curanex Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Curanex Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 K, Selling General Administrative of 350.6 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 5.2 K, Dividend Yield of 0.0 or PTB Ratio of 242. Curanex financial statements analysis is a perfect complement when working with Curanex Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Curanex Stock
Check out the analysis of Curanex Pharmaceuticals Correlation against competitors.

Curanex Pharmaceuticals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets625.4 K595.6 K114.5 K
Slightly volatile
Total Stockholder Equity607.8 K578.9 K110.8 K
Slightly volatile
Cash179.8 K171.2 K35.6 K
Slightly volatile
Common Stock Shares Outstanding29.8 M25 M39.4 M
Slightly volatile
Other Current Assets445.6 K424.4 K96 K
Slightly volatile
Net Invested Capital607.7 K578.7 K110.8 K
Slightly volatile
Total Current Assets625.4 K595.6 K114.5 K
Slightly volatile
Capital StockK2.9 K574
Slightly volatile
Net Working Capital607.8 K578.9 K110.8 K
Slightly volatile
Other Current Liabilities9.3 K8.6 K12.9 K
Slightly volatile
Cash And Short Term Investments122.8 K171.2 K87.3 K
Slightly volatile
Liabilities And Stockholders Equity325.8 K595.6 K145.9 K
Slightly volatile
Other Stockholder Equity794.4 K1.3 M453.1 K
Slightly volatile
Common Stock2.9 K2.8 K523
Slightly volatile

Curanex Pharmaceuticals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.6 K1.6 K16.6 K
Slightly volatile
Selling General Administrative350.6 K333.9 K77.3 K
Slightly volatile
Other Operating Expenses440.8 K419.8 K108.6 K
Slightly volatile
Total Operating Expenses440.8 K419.8 K92.1 K
Slightly volatile
Total Other Income Expense Net4.3 K4.1 K785
Slightly volatile

Curanex Pharmaceuticals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change In Cash53.8 K85.7 K17.1 K
Slightly volatile
Begin Period Cash Flow89.8 K85.5 K16.4 K
Slightly volatile
End Period Cash Flow179.8 K171.2 K35.6 K
Slightly volatile
Other Cashflows From Financing Activities85.590.02.5 K
Slightly volatile
Other Non Cash Items59.7 K67.2 K73.4 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.2 K5.8 K6.4 K
Slightly volatile
PTB Ratio2422552.4 K
Slightly volatile
Book Value Per Share0.01710.01630.0042
Slightly volatile
PB Ratio2422552.4 K
Slightly volatile
Sales General And Administrative To Revenue0.760.850.9317
Slightly volatile
Cash Per Share0.00290.00480.0022
Slightly volatile
Income Quality1.451.380.262
Slightly volatile
Net Debt To EBITDA0.560.593.6008
Slightly volatile
Current Ratio16.331.989.2202
Slightly volatile
Tangible Book Value Per Share0.01710.01630.0042
Slightly volatile
Shareholders Equity Per Share0.01710.01630.0042
Slightly volatile
Graham Net Net0.00250.00440.0019
Slightly volatile
Revenue Per Share5.0E-46.0E-46.0E-4
Slightly volatile
Price Book Value Ratio2422552.4 K
Slightly volatile
Ebt Per Ebit1.091.141.0087
Slightly volatile
Company Equity Multiplier1.241.181.2221
Slightly volatile
Quick Ratio16.331.989.2202
Slightly volatile
Cash Ratio6.179.195.7943
Slightly volatile
Price To Book Ratio2422552.4 K
Slightly volatile
Price Sales Ratio5.2 K5.8 K6.4 K
Slightly volatile
Gross Profit Margin0.140.150.1674
Slightly volatile
Price Fair Value2422552.4 K
Slightly volatile

Curanex Pharmaceuticals Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap164.7 M128.3 M162.8 M
Slightly volatile
Enterprise Value154.1 M128.1 M162.1 M
Slightly volatile

Curanex Fundamental Market Drivers

About Curanex Pharmaceuticals Financial Statements

Curanex Pharmaceuticals investors use historical fundamental indicators, such as Curanex Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Curanex Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sales General And Administrative To Revenue 0.85  0.76 
Ebit Per Revenue(0.70)(0.74)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Curanex Stock Analysis

When running Curanex Pharmaceuticals' price analysis, check to measure Curanex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curanex Pharmaceuticals is operating at the current time. Most of Curanex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Curanex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curanex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Curanex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.